Biggest News Aggregation in the World
📰 James Basta News

James Basta News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from James Basta. Real-time updates on events, politics, business and more.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Contrarius Investment Management Ltd

Contrarius Investment Management Ltd decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 214,401 shares of the company’s stock after selling 17,461 shares during the quarter. Contrarius Investment Management Ltd owned […]
New Zealand General New Zealand James Basta Wolfe Research Hermes Inc Canaccord Genuity Group

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is Merlin Capital Inc's 4th Largest Position

Merlin Capital Inc raised its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 44.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 26,834 shares of the company’s stock after acquiring an additional 8,308 shares during the period. Intellia Therapeutics makes up 2.6% of Merlin Capital Inc’s investment portfolio, making the stock […]
James Basta Pathstone Family Office Daiwa Securities Group Inc Goldman Sachs Group Wolfe Research China Universal Asset Management Co

Merlin Capital Inc Has $818,000 Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Merlin Capital Inc lifted its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 44.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,834 shares of the company’s stock after buying an additional 8,308 shares during the period. Intellia Therapeutics comprises […]
James Basta Goldman Sachs Group Wolfe Research Merlin Capital Inc Canaccord Genuity Group Harbor Capital Advisors Inc

Jennison Associates LLC Has $727,000 Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Jennison Associates LLC grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,848 shares of the company’s stock after purchasing an additional 4,949 shares during the period. Jennison Associates LLC’s holdings in […]
James Basta Pathstone Family Office Securities Exchange Commission Jennison Associates Goldman Sachs Group Intellia Therapeutics Inc

abrdn plc Buys New Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Abrdn plc bought a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 154,269 shares of the company’s stock, valued at approximately $4,704,000. abrdn plc owned about 0.17% of Intellia Therapeutics as […]
New Zealand General New Zealand United States James Basta Intellia Therapeutics Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Wedbush Reiterates Neutral Rating for Intellia Therapeutics (NASDAQ:NTLA)

Wedbush reiterated their neutral rating on shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $29.00 target price on the stock. A number of other equities research analysts also recently weighed in on NTLA. Wolfe Research assumed coverage on Intellia Therapeutics in a […]
United States New Zealand General New Zealand James Basta Wellington Management Group Canaccord Genuity Group
Source: wkrb13.com

Resonant Capital Advisors LLC Raises Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Resonant Capital Advisors LLC lifted its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 32.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 41,348 shares of the company’s stock after buying an additional 10,082 shares during the quarter. Resonant Capital Advisors LLC’s holdings in Intellia Therapeutics were worth $1,261,000 […]
James Basta Canaccord Genuity Group Metlife Investment Management Resonant Capital Advisors Goldman Sachs Group Blair William Co
Source: wkrb13.com

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price […]
James Basta Investment Management Goldman Sachs Group Wolfe Research Morgan Stanley Norges Bank
Source: wkrb13.com

Chevy Chase Trust Holdings LLC Sells 11,780 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Chevy Chase Trust Holdings LLC decreased its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 991,175 shares of the company’s stock after selling 11,780 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Intellia Therapeutics were worth $30,221,000 at the […]
Laura Sepp Lorenzino James Basta Goldman Sachs Group Chevy Chase Trust Holdings China Universal Asset Management Co Canaccord Genuity Group
Source: wkrb13.com

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. grew its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 357.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 10,355 shares of the company’s stock after acquiring an additional 8,092 shares during the quarter. China Universal […]
James Basta Laura Sepp Lorenzino Raymond James Associates Blue Trust Inc Canaccord Genuity Group Raymond James Financial Services Advisors Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science